Company / Cash per Share
Arrowhead Pharmaceuticals Cash per Share History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.80
FY2021
5-year range
$1.80 / $1.80
FY2017-FY2021
Trend
+19.8%
vs FY2020
Sector context
#115 of 205
Health Care
What the data says
At $1.80, Arrowhead Pharmaceuticals's cash per share ranks #115 of 205 in the Health Care sector. Cash per Share has fluctuated over the past 6 years, ranging from $0.33 in FY2018 to $2.51 in FY2019.
Based on SEC 10-K filings.
1.80 in FY2021 with a 5-year CAGR of +4.7%.
Declined from $2.51 to $1.80 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +75.7%
- 5-Year CAGR
- +4.7%
- 10-Year CAGR
- -
Sector benchmark
#115 of 205 in Health CareTop 56% of 205This company $1.80 Sector average $72.93
▼
-97.5% below sector average
Key checks
Key Insights
- In FY2021, cash per share increased 19.8% year-over-year.
- Ranks #115 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2019.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $1.80 | +19.8% |
| FY2020 | $1.50 | -40.0% |
| FY2019 | $2.51 | +654.6% |
| FY2018 | $0.33 | -71.5% |
| FY2017 | $1.16 | -18.8% |
| FY2016 | $1.43 | +309.9% |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026